Trial Profile
A phase I safety study of the Ebola virus vaccine in healthy adults in Nigeria
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 02 Sep 2014
Price :
$35
*
At a glance
- Drugs GSK 3390107A (Primary)
- Indications Ebola virus infections
- Focus Adverse reactions
- 02 Sep 2014 New trial record